Paper: Pre-Apheresis Prediction of Toxicity and Response in Patients Receiving BCMA-Directed CAR-T for Relapsed/Refractory Multiple Myeloma

Program: Oral and Poster Abstracts Type: Oral Session: 653. Multiple Myeloma: Clinical and Epidemiological: Exploring T Cell Redirecting Therapies, Mutation Profiles and Early Relapse Hematology Disease Topics & Pathways: Research, Adult, Plasma Cell Disorders, Clinical Research, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Diseases, Treatment Considerations, Biological therapies, Real-world evidence, Adverse Events, Lymphoid Malignancies, Study Population, Human Kai Rejeski, MD 1,2, Doris K. Hansen,

Read the full article here

Source: ash.confex.com

Categories: Hem/Oncs, General Medicine News

Tags: ASH24,mmsm,CARTcell

Tweets with this article

Mike Thompson, MD, PhD, FASCO

Pre-Apheresis Prediction of Toxicity and Response in Patients Receiving BCMA-Directed CAR-T for Relapsed/Refractory Multiple Myeloma [Dec 9, 2024] Rejeski et al. #ASH24 895 https://t.co/mNeaEM1atO #mmsm #CARTcell HT @jmikhaelmd

Short-course hypofractionated proton beam therapy, incorporating 18F-DOPA PET and contrast-enhanced MRI targeting, for patients aged 65 years and older with newly diagnosed glioblastoma: a single-arm phase 2 trial

We observed improved overall survival compared with historical controls and a promising adverse event profile by using 18F-DOPA PET−guided, dose-escalated, hypofractionated proton beam therapy. These…

Ari E. Marciscano, MD November 19, 2024

Toni Choueiri: Honored by the King Hussein Cancer Foundation – OncoDaily

Toni Choueiri: Honored by the King Hussein Cancer Foundation / cancer, Dana-Farber Cancer Institute, DFCI, HRH Princess Ghida Talal, King Hussein Cancer

Leigh Ellis November 19, 2024

Werder Bremen to leave X | SV Werder Bremen

SV Werder Bremen’s executive board have decided that the club will leave the social media platform ‘X’ (formerly Twitter). The announcement was made by Klaus…

Rod Rassekh November 19, 2024

How ‘Scientific American’s departing editor helped degrade science

When magazines like ‘Scientific American’ are run by ideologues producing biased dreck, it only makes it more difficult to defend the institution of science itself.

Vinay Prasad November 19, 2024

Paper: Sustained MRD Negativity for Three Years Can Guide Discontinuation of Lenalidomide Maintenance after ASCT in Multiple Myeloma: Results from a Prospective Cohort Study

Program: Oral and Poster Abstracts Type: Oral Session: 653. Multiple Myeloma: Clinical and Epidemiological: Advancing Minimal Residual Disease (MRD): Detection, Impact on Prognosis and Treatment…

Muzaffar Qazilbash November 19, 2024

#HTTR24 – HTTR24 – Hilton DC National Mall The Wharf

This conference is a premier gathering of leading minds in lung and thoracic cancer research. It offers a unique platform to discuss the latest advancements,…

Stephen V Liu November 19, 2024

Paper: Optimal MRD-Based Endpoint in the Setting of Upfront Quadruplets (QUADs) to Support Response-Adapted Treatment Cessation in Newly Diagnosed Multiple Myeloma (NDMM)

Program: Oral and Poster Abstracts Type: Oral Session: 653. Multiple Myeloma: Clinical and Epidemiological: Addressing Hematologic and Immune Toxicities and the Status of Quad Therapies…

Muzaffar Qazilbash November 19, 2024

A Simple Litmus Test for RFK Jr.’s Ideas

The media describes the new HHS chief as a conspiracy theorist. But how many of his ideas are actually used in Europe? More than you’d…

Vinay Prasad November 19, 2024

Paper: Effects of Intravenous Immunoglobulin Supplementation (IVIG) on Infections in Recipients of Teclistamab Therapy for Multiple Myeloma (MM): A Multi-Institutional Study

Program: Oral and Poster Abstracts Type: Oral Session: 653. Multiple Myeloma: Clinical and Epidemiological: Addressing Hematologic and Immune Toxicities and the Status of Quad Therapies…

Rahul Banerjee, MD November 19, 2024

Antidiabetic Medication and Asthma Attacks

This cohort study examines the association of treatment with metformin and add-on antidiabetic medications with asthma attacks.

Ash Paul November 19, 2024

Related Articles